IRIS

CAPORASO, NICOLA

CAPORASO, NICOLA  

DIPARTIMENTO DI MEDICINA CLINICA E CHIRURGIA  

Mostra records
Risultati 1 - 20 di 352 (tempo di esecuzione: 0.039 secondi).
Titolo Tipologia Data di pubblicazione Autore(i) File
Long-term outcome of interferon-alfa induced thyroid autoimmunity and prognostic influence of thyroid autoantibodies pattern at the end of treatment. 1.1 Articolo in rivista 2001 Carella, C; Mazziotti, G; Morisco, Filomena; Manganella, G; Rotondi, M; Tuccillo, C; Sorvillo, F; Caporaso, Nicola; Amato, G.
Temporal relationship between the appearance of thyroid autoantibodies and development of destructive thyroiditis in patients undergoing treatment with two different type-1interferons for HCV-related chronic hepatitis: A prospective study. 1.1 Articolo in rivista 2002 Mazziotti, G; Sorvillo, F; Stornaiuolo, G; Rotondi, M; Morisco, Filomena; Ruberto, M; Cioffi, M; Amato, G; Caporaso, Nicola; Gaeta, Gb; Carella, C.
The addiction of ribavirin to interferon-alpha therapy in patients with hepatitis C virus-related chronic hepatitis does not modify the thyroid autoantibody pattern but increases the risk of developing hypothyroidism. 1.1 Articolo in rivista 2002 Carella, C; Mazziotti, G; Morisco, Filomena; Rotondi, M; Cioffi, M; Tuccillo, C; Sorvillo, F; Caporaso, Nicola; Amato, G.
Incidence of site effects during therapy with different types of alpha interferon: a randomized controlled trial compared recombinant alpha 2-b versus leukocyte interferon in the therapy of naives patients with chronic hepatitis C 1.1 Articolo in rivista 2002 Ascione, A; DE LUCA, M; DI COSTANZO, Gg; Picciotto, Fp; GALEOTA LANZA, A; Canestrini, C; Morisco, Filomena; Tuccillo, C; Caporaso, Nicola
Interferon-related thyroid autoimmunity and long-term clinical outcome of chronic hepatitis C. 1.1 Articolo in rivista 2001 Morisco, Filomena; Mazziotti, G; Rotondi, M; Tuccillo, C; Iasevoli, P; DEL BUONO, A; Sorvillo, F; Amato, G; Marmo, R; Caporaso, Nicola; Carella, C.
Delta hepatitis in inapparent carriers of hepatitis B surface antigen. A disease simulating acute hepatitis B progressive to chronicity 1.1 Articolo in rivista 1983 Farci, P; Smedile, A; Lavarini, C; Piantino, P; Crivelli, O; Caporaso, Nicola; Toti, M; Bonino, F; Rizzetto, M.
Membranous glomerulopathy and hepatitis B virus (HBV) infection in children 1.1 Articolo in rivista 1983 Del Vecchio Blanco, C; Polito, C; Caporaso, Nicola; Del Gado, R; Busachi, Ca; Coltorti, M; Di Toro, R.
Safe use of ursodeoxycholic acid in the treatment of dyspeptic symptoms in patients with chronic active hepatitis: a double-blind controlled trial. 1.1 Articolo in rivista 1982 Del Vecchio Blanco, C; Caporaso, Nicola; Gentile, S; Rinaldi, M; Pucci, R.
Spread of hepatitis C virus infection within families 1.1 Articolo in rivista 1998 Caporaso, Nicola; Ascione, A; Stroffolini, T; INVESTIGATORS OF AN ITALIAN MULTICENTER, Group; Morisco, Filomena
Chronic hepatitis C: Interferon retreatment of relapsers. A Meta-analysis of individual patient data. 1.1 Articolo in rivista 1999 Camma'C, ; Giunta, M; Chemello, L; Alberti, A; Toyoda, H; Trepo, C; Marcellin, P; Zahm, F; Schalm, S; Craxi', A; Caporaso, Nicola
Tamoxifen in treatment of hepatocellular carcinoma: a randomised controlled trial. 1.1 Articolo in rivista 1998 THE CANCER OF THE LIVER, Programme; Caporaso, Nicola
A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients 1.1 Articolo in rivista 1998 THE CLIP, Investigators; Caporaso, Nicola
Intrafamilial transmission of hepatitis delta virus: molecular evidence. 1.1 Articolo in rivista 1999 Niro, Ga; Casey, Jl; Gravinese, E; Garruba, M; Conoscitore, P; Sagnelli, E; Durazzo, M; Caporaso, Nicola; Perri, F; Leandro, G; Facciorusso, D; Rizzetto, M.
Serum insulin-like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a prospective study. 1.1 Articolo in rivista 2002 Mazziotti, G; Sorvillo, F; Morisco, Filomena; Carbone, A; Rotondi, M; Stornaiuolo, G; Precone, D; Cioffi, M; Gaeta, Gb; Caporaso, Nicola; Carella, C.
Quality of life assessment in chronic liver disease. 1.1 Articolo in rivista 2002 Cirrincione, R; Taliani, G; Caporaso, Nicola; Mele, A.
Therapy expectations and physical comorbidity affect quality of life in chronic hepatitis C virus infection. 1.1 Articolo in rivista 2007 Taliani, G; Rucci, P; Biliotti, E; Cirrincione, L; Aghemo, A; Alberti, A; Almasio, Pl; Bartolozzi, D; Caporaso, Nicola; Coppola, R; Chiaramonte, M; Floreani, A; Gaeta, Gb; Persico, M; Secchi, G; Versace, I; Zacharia, S; Mele, A.
Prevalence of HBcAg and delta-Ag in liver tissue of patients with HBsAg positive chronic hepatitis 1.1 Articolo in rivista 1988 Di Sapio, M; Caporaso, Nicola; Del Vecchio Blanco, C; Coltorti, M.
Hepatitis B variant in Europe 1.1 Articolo in rivista 1988 Zanetti, Ar; Tanzi, E; Manzillo, G; Maio, G; Sbreglia, C; Caporaso, Nicola; Thomas, H; Zuckerman, Aj
Phenotypic characterization of mononuclear cell infiltrate in chronic active hepatitis (CAH) of different etiology 1.1 Articolo in rivista 1987 Di Sapio, M; Focareta, R; Caporaso, Nicola; Del Vecchio Blanco, C; Coltorti, M.
Clinical significance of antibody to the hepatitis delta virus in symptomless HBsAg carriers 1.1 Articolo in rivista 1985 Arico, S; Aragona, M; Rizzetto, M; Caredda, F; Zanetti, A; Marinucci, G; Diana, S; Farci, P; Arnone, M; Caporaso, Nicola